Web notes  
May 2013
PUBLICATIONS - Back

Oncology
[Oncology archives]

1. Bolaños-Meade J, Wu J, Logan BR, Levine JE, Ho VT, Alousi AM, Weisdorf DJ, Luznik L; Blood and Marrow Transplant Clinical Trials Network. Lymphocyte phenotype during therapy for acute graft-versus-host disease: a brief report from BMT-CTN 0302. Biol Blood Marrow Transplant. 2013 Mar;19(3):481-5. doi: 10.1016/j.bbmt.2012.12.003. Epub 2012 Dec 12.
Key words: transplant, blood, marrow, lymphocyte
http://www.ncbi.nlm.nih.gov/pubmed/23247045

2. Campian JL, Ye X, Brock M, Grossman SA. Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer. Cancer Invest. 2013 Mar;31(3):183-8. doi: 10.3109/07357907.2013.767342.
Key words: lung cancer, lymphopenia, stage III
http://www.ncbi.nlm.nih.gov/pubmed/23432821

3. Connolly R, Stearns V. Current approaches for neoadjuvant chemotherapy in breast cancer. Eur J Pharmacol. 2013 Mar 29. doi:pii: S0014-2999(13)00251-3. 10.1016/j.ejphar.2013.02.057. [Epub ahead of print]
Key words: breast cancer, neoadjuvant, chemotherapy
http://www.ncbi.nlm.nih.gov/pubmed/23545358

4. Cope L, Wu RC, Shih IeM, Wang TL. High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome. Gynecol Oncol. 2013 Mar;128(3):500-5. doi: 10.1016/j.ygyno.2012.11.031. Epub 2012 Nov 28.
Key words: ovarian cancer, genome, aberration, chromosomal
http://www.ncbi.nlm.nih.gov/pubmed/23200914

5. Durand CM, Ambinder RF. Hematopoietic stem cell transplantation in HIV-1-infected individuals: clinical challenges and the potential for viral eradication. Curr Opin Oncol. 2013 Mar;25(2):180-6. doi: 10.1097/CCO.0b013e32835d814a.
Key words: HIV, hematopoietic, eradication
http://www.ncbi.nlm.nih.gov/pubmed/23385862

6. Holdhoff M, Rosner GL, Alcorn S, Grossman SA. 'Elderly' patients with newly diagnosed glioblastoma deserve optimal care. J Neurooncol. 2013 Mar 23. [Epub ahead of print]
Key words: glioblastoma, elderly
http://www.ncbi.nlm.nih.gov/pubmed/23526408

7. Hossain MZ, Gilbert SF, Patel K, Ghosh S, Bhunia AK, Kern SE. Biological clues to potent DNA-damaging activities in food and flavoring. Food Chem Toxicol. 2013 May;55:557-67. doi: 10.1016/j.fct.2013.01.058. Epub 2013 Feb 8.
Key words: DNA damage, food, flavoring
http://www.ncbi.nlm.nih.gov/pubmed/23402862

8. Manning ML, Williams SA, Jelinek CA, Kostova MB, Denmeade SR. Proteolysis of complement factors iC3b and C5 by the serine protease prostate-specific antigen in prostatic fluid and seminal plasma. J Immunol. 2013 Mar 15;190(6):2567-74. doi: 10.4049/jimmunol.1200856. Epub 2013 Feb 11.
Key words: prostate cancer, seminal plasma, iC3b
http://www.ncbi.nlm.nih.gov/pubmed/23401592

9. Murray-Stewart T, Woster PM, Casero RA Jr. The re-expression of the epigenetically silenced e-cadherin gene by a polyamine analogue lysine-specific demethylase-1 (LSD1) inhibitor in human acute myeloid leukemia cell lines. Amino Acids. 2013 Mar 19. [Epub ahead of print]
Key words: leukemia, cadherin, demethylase, myeloid
http://www.ncbi.nlm.nih.gov/pubmed/23508577

10. Rudin CM, Brahmer JR, Juergens RA, Hann CL, Ettinger DS, Sebree R, Smith R, Aftab BT, Huang P, Liu JO. Phase 2 study of pemetrexed and itraconazole as second-line therapy for metastatic nonsquamous non-small-cell lung cancer. J Thorac Oncol. 2013 Mar 29. [Epub ahead of print]
Key words: pemetrexed, lung cancer, metastatic
http://www.ncbi.nlm.nih.gov/pubmed/23546045

11. Rudin CM, Hong K, Streit M. Molecular characterization of acquired resistance to the BRAF inhibitor dabrafenib in a patient with BRAF-mutant non-small-cell lung cancer. J Thorac Oncol. 2013 Mar 21. [Epub ahead of print]
Key words: lung cancer, dabrafenib
http://www.ncbi.nlm.nih.gov/pubmed/23524406

12. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122. Review.
Key words: cancer, genome, landscapes
http://www.ncbi.nlm.nih.gov/pubmed/23539594

13. Zinn RL, Gardner EE, Dobromilskaya I, Murphy S, Marchionni L, Hann CL, Rudin CM. Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Mol Cancer. 2013 Mar 2;12:16. doi: 10.1186/1476-4598-12-16.
Key words: lung cancer, chloroquine
http://www.ncbi.nlm.nih.gov/pubmed/23452820

14. Zinn RL, Gardner EE, Marchionni L, Murphy SC, Dobromilskaya I, Hann CL, Rudin CM. ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer. Mol Cancer Ther. 2013 Mar 20. [Epub ahead of print]
Key words: lung cancer, IGF-1R, ERK
http://www.ncbi.nlm.nih.gov/pubmed/23515613

15. Yegnasubramanian S, Maitra A. Aiming for the outliers: cancer precision medicine through targeting kinases with extreme expression. Cancer Discov. 2013 Mar;3(3):252-4. doi: 10.1158/2159-8290.CD-13-0016.
Key words: kinases, expression, outliers
http://www.ncbi.nlm.nih.gov/pubmed/23475875

 

Return to top of Publications - Oncology

Search Publications
 
   
May 2013 articles:
Visit Animal Care and Use Committee Website
Current Classes
Funding from Foundations/Private Sources
Harrington Discovery Institute Scholar Innovator Grant Competition
Hartwell Biomedical Research Award
Brain Research Foundation-Scientific Innovations Award for 2014
NIH Office of Research Infrastructure High-End Instrumentation Grant (HEI) program
Johns Hopkins Clinical Research Network
Hopkins Conte Digestive Disease Basic & Translational Research Core Center

This Month's Departmental Listings

Upcoming Deadlines for May and July

       

 

JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 

 

                                                                                                                                                           The Web Center